Tisbury Pharmaceutical

Tavo Biotherapeutics

The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.

VISUfarma

This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Envisia

This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.

Aquesys

This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.